<DOC>
	<DOCNO>NCT02494726</DOCNO>
	<brief_summary>The overall purpose study evaluate effective Thromboelastography ( TEG ) identify ischemic hemorrhagic stroke patient increase risk bleed receive tissue plasminogen activator ( tPA ) , well differentiate patient optimal thrombolysis achieve , .</brief_summary>
	<brief_title>Prospective Analysis Use TEG Stroke Patients</brief_title>
	<detailed_description>Thromboelastography ( TEG ) , computerized analysis use since 1940s , stand alone test provide integrate information balance two separate simultaneously occur component coagulation , thrombosis lysis . It measure coagulation process initial clot cascade clot strength . TEG may use assess coagulation status patient acute stroke , whether ischemic hemorrhagic . TEG might also useful way predict ass degree fibrinolysis achieve tissue plasminogen activator ( tPA ) . Currently tPA give standard dose determine patient 's body weight , thus give variability patient outcome tPA , dose could sometimes small large , leading thrombolysis bleeding , respectively . One purpose observational study evaluate effective TEG predict assess degree thrombolysis follow tPA therapy , produce range TEG value correlate optimal thrombolysis . The result recent FAST trial demonstrate need identify patient spontaneous intracerebral hemorrhage ( ICH ) increase risk hematoma enlargement . Such identified patient , could benefit therapeutic advantage activate factor VII hemostatic agent may clearly study . Therefore , another purpose study evaluate effective TEG predict bleed patient spontaneous ICH . The study consist 208 ischemic patient 80 hemorrhagic patient , approach stroke patient admit Memorial Hermann Hospital Emergency Department receive confirmatory CT MRI scan . Patients agree participate blood drawn day hospital arrival , follow 36 +/- 12 hour stroke , 90 +/- 30 day stroke , two blood sample obtain . Normal control age sex match investigator ' research population . A one-time blood draw obtain information collect age , sex TEG value .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Intracranial Hemorrhages</mesh_term>
	<criteria>At least 18 year age old . Symptoms sign cause measurable neurologic deficit consistent acute stroke . CT MRI consistent stroke ( ischemic hemorrhagic ) clinical evidence suggest stroke . For acute ischemic stroke patient , treatment tPA TEG blood draw must do within 4.5 hour symptom onset . For ICH patient , TEG blood draw must do within 6 hour symptom onset . Contraindication CT MRI ( ex . inability lie flat ) If ICH patient Hemorrhage secondary trauma , arteriovenous malformation ( AVM ) crush injury Planned surgical evacuation ( hemicraniectomy ventriculostomy allow ) . Receipt hemostatic agent ( FFP , Cryo , activate factor seven ) prior TEG blood draw .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Ischemic stroke</keyword>
	<keyword>ICH stroke</keyword>
	<keyword>TEG</keyword>
	<keyword>Thromboelastography</keyword>
	<keyword>Stroke</keyword>
</DOC>